CEO Keith Grossman details how `Pain Company’ Nevro is grabbing a big piece of a competitive market

CEO Keith Grossman details how `Pain Company’ Nevro is grabbing a big piece of a competitive market
DeviceTalks Podcast Network
CEO Keith Grossman details how `Pain Company’ Nevro is grabbing a big piece of a competitive market

Nov 11 2022 | 00:49:41

/
Episode November 11, 2022 00:49:41

Hosted By

Kayleen Brown Tom Salemi

Show Notes

In this episode, we’ll talk with Keith Grossman, who brought his long, successful track record as a medtech CEO to what he sees as a truly disruptive neurostimulation company. We’ll talk with Grossman about his decision to join medtech even though unlike some of his counterparts he enjoyed organic chemistry (aka, the Medtech career creator) in college. Over his career, Grossman helped create new medical device marks by leading companies such as Thoratec and Conceptus toward sizable acquisitions. At Nevro, Grossman says he’s overseeing the company’s transformation into a pain company, one that’s managed to grab 20% of a competitive market very quickly. Thanks to Pulse Technologies for sponsoring this episode. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to this podcast on any major podcast application.

Other Episodes